Skip to main content

KetoSwiss secures capital increase of 4 million dollars

| News

KetoSwiss secures capital increase of 4 million dollars

14.10.2022

KetoSwiss has banked a total of 4 million US dollars from investors. The Basel-based startup develops products to alleviate neurological diseases such as migraines and brain ageing. KetoSwiss is now preparing to enter the US market in the first half of 2023 in addition to advancing clinical trials.

Our brain needs energy. KetoSwiss develops “brain fuels” (img: Screenshot of video from KetoSwiss)

KetoSwiss has raised a total of 4 million US dollars as part of a pre-Series A financing round. The Basel-based startup specializes in the area of brain metabolism and the role ketones play in this. With MigraKet, its first medical product under the Brain Ritual brand, KetoSwiss is seeking to support the fight against migraines.

Ketones or ketone bodies are the breakdown products of fat metabolism. If body cells do not receive enough glucose over a longer period of time, for example when starving or on a ketogenic diet, the body burns fat instead of glucose. The ketones produced in the kidneys can be used by the cells to meet their energy needs and heal inflammation.

Market launch in USA

According to an article on startupticker.ch, KetoSwiss will use the fresh capital to prepare for the market launch of its Brain Ritual brand in the USA in the first half of 2023 and is expanding the US-based arm of the company. In addition, the startup is keen to achieve further R&D and clinical trial milestones. For example, the effects of MigraKet on brain function as well as on depression and other mental illnesses are to be examined.

The financing round was led by the North American William K. Karren Foundation, which supports research into neuropsychiatric disorders. Other investors involved include the venture capital firm R42 and the venture capital fund Healthspan Capital, both of which are based in the USA. They invest in biotechnology for longevity and regenerative medicine.

Basel Area Business & Innovation, the investment and innovation promotion agency, supported the startup via its Venture Mentoring program.

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

biGENIUS receives 2 million euros for new cloud product

Software company biGENIUS, based in the Basel Area, has secured financing of 2 million euros. This funding was granted following...
Read More

Opterion Health secures investment of 6.5 million Swiss francs

Opterion Health has raised a total of 6.5 million Swiss francs as part of a financing round. The company, which...
Read More

TOLREMO receives 39 million US dollars in investments

TOLREMO Therapeutics has concluded a series A funding round with 39 million US dollars. The biotech company based in Basel...
Read More

Mazars opens tenth Swiss office in Basel

Mazars is now also present in Basel with a subsidiary as of September 1. This is the tenth Swiss location...
Read More

Medtech in Switzerland – bringing together traditional skills and hightech industry

How the intersection of traditional and novel skillsets in the Jura area is propelling Switzerland into a new era of...
Read More

Fondation Botnar supporting further research into pediatric health

The Basel-based Botnar Research Centre for Child Health has received a further donation of 50 million Swiss francs from the...
Read More

Do you have a question? We'd like to hear from you.